Organoids As a Model for Drug Testing and Disease Research

Organoid technology has transformed biomedical research by providing sophisticated 3D models that mimic human tissues with high accuracy. Compared to traditional 2D cultures and animal models, organoids offer a more precise depiction of human physiology, making them essential for drug testing, disease research, and regenerative therapies. Developed from pluripotent or adult stem cells, organoids can mimic organ-specific functions, enabling large-scale drug screening, toxicity assessments, and personalized treatment evaluations. Organoids have diverse applications in fields such as oncology, neurology, and infectious diseases, offering insights into disease progression and treatment responses. They provide superior physiological accuracy, minimize dependence on animal testing, and contribute to advancements in personalized medicine. However, challenges such as reproducibility, scalability, ethical concerns, and high production costs must be addressed. Future advancements, including bioengineering, artificial intelligence, and organ-on-chip technologies, will further refine their clinical applications. This review explores the development, benefits, limitations, and future potential of organoid technology, emphasizing its role in transforming drug development and precision medicine. By overcoming current limitations, organoids hold the promise of revolutionizing biomedical research and improving treatment strategies for various diseases.